|
End-of-day quote
Johannesburg S.E.
2026-08-24
|
5-day change | 1st Jan Change | ||
| 147.04 ZAR | -0.40% |
|
+3.59% | +25.90% |
| 07-20 | Aspen Pharmacare wins Canada approval for generic Ozempic after Novo patent expiry | RE |
| 07-20 | Aspen Pharmacare wins Canada approval for generic Ozempic injection | RE |
| Market Cap | 65.29B 4.08B 3.5B 3.27B 2.99B 5.64B 391B 5.7B 38.7B 15.05B 196B 15.32B 14.98B 649B | P/E 2026 * |
14.9x | P/E 2027 * | 12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 78.17B 4.88B 4.19B 3.92B 3.58B 6.76B 468B 6.83B 46.33B 18.02B 235B 18.34B 17.94B 777B | EV / Sales 2026 * |
2.08x | EV / Sales 2027 * | 1.64x |
| Free-Float |
59.64% | Yield 2026 * |
1.81% | Yield 2027 * | 1.71% |
Last Transcript: Aspen Pharmacare Holdings Limited
| 1 day | -0.40% | ||
| 1 week | +3.59% | ||
| Current month | -1.38% | ||
| 1 month | +0.71% | ||
| 3 months | +8.52% | ||
| 6 months | +13.21% | ||
| Current year | +25.90% |
| 1 week | 137.96 |  | 150.46 |
| 1 month | 137.96 | | 154.04 |
| Current year | 104.38 | | 160.79 |
| 1 year | 90.7 | | 160.79 |
| 3 years | 90.7 | | 252.96 |
| 5 years | 90.7 | | 281.67 |
| 10 years | 64.07 | | 365.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Saad
CEO | Chief Executive Officer | 62 | 1996-12-31 |
Sean Capazorio
DFI | Director of Finance/CFO | 61 | 2008-12-31 |
| Chief Operating Officer | 63 | 1998-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Saad
BRD | Director/Board Member | 62 | 1998-12-31 |
| Director/Board Member | 65 | 1998-12-31 | |
Kuseni Dlamini
CHM | Chairman | 58 | 2015-12-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 9/27/23 | Free | Chief Operating Officer | 12,236 | 0.0027% | ||
| 9/27/23 | Free | Executive/Senior Manager | 11,728 | 0.0026% | ||
| 9/27/23 | Free | Founder | 10,558 | 0.0024% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.40% | +3.59% | +41.32% | -21.37% | 4.09B | |
| +0.40% | +1.49% | +16.34% | +70.79% | 47.71B | |
| -0.94% | +0.46% | +50.81% | +124.11% | 40.3B | |
| +0.40% | +0.45% | -9.73% | +17.81% | 12.09B | |
| -1.45% | -2.45% | +11.63% | +72.24% | 11.68B | |
| +0.19% | 0.00% | +30.98% | +154.90% | 9.19B | |
| +3.49% | +2.54% | +24.70% | +46.08% | 7.57B | |
| -0.08% | +0.06% | +46.62% | -11.44% | 7.24B | |
| +3.14% | +2.65% | +23.40% | +219.12% | 6.84B | |
| -3.24% | -9.97% | -40.05% | +13.62% | 5.42B | |
| Average | +0.15% | -0.75% | +19.60% | +68.59% | 15.21B | |
| Weighted average by Cap. | -0.01% | -0.51% | +24.76% | +82.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.62B 2.35B 2.01B 1.88B 1.72B 3.25B 225B 3.29B 22.3B 8.67B 113B 8.83B 8.63B 374B | 38.86B 2.43B 2.08B 1.95B 1.78B 3.36B 232B 3.39B 23.03B 8.96B 117B 9.12B 8.92B 386B |
| Net income | 4.8B 300M 257M 240M 220M 415M 28.7B 419M 2.84B 1.11B 14.41B 1.13B 1.1B 47.69B | 5B 312M 267M 250M 229M 432M 29.89B 436M 2.96B 1.15B 15.01B 1.17B 1.15B 49.65B |
| Net Debt | 12.88B 805M 690M 645M 590M 1.11B 77.04B 1.12B 7.63B 2.97B 38.69B 3.02B 2.96B 128B | -1.74B -108M -92.91M -86.92M -79.47M -150M -10.38B -152M -1.03B -400M -5.21B -407M -398M -17.25B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-24 | ZAR 147.04 | -0.40% | 866,611 |
| 26-08-21 | ZAR 147.63 | +2.78% | 1,852,160 |
| 26-08-20 | ZAR 143.64 | +1.24% | 1,177,610 |
| 26-08-19 | ZAR 141.88 | +0.95% | 2,706,198 |
| 26-08-18 | ZAR 140.55 | -0.98% | 3,249,353 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- APN Stock
Select your edition
All financial news and data tailored to specific country editions
